The condition is a major unmet medical need. Actimed Therapeutics is working to address this major unmet medical need by developing a new class of agents to treat cancer cachexia. As patients with ...

Will focus on fund raising efforts to support the planned IMPACT Phase 2b/3 trial for S-pindolol benzoate in cancer cachexia Professor Stefan Anker, Co-Founder of Actimed and Chair of the ...

Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting ...

Professor David Ebsworth to work closely alongside CEO Robin Bhattacherjee Will focus on fund raising efforts to support the planned IMPACT Phase 2b/3 trial for S-pindolol benzoate in cancer cachexia ...